Researchers led by the National Heart, Lung, and Blood Institute report that menopausal hormone therapy relieved vasomotor symptoms without raising cardiovascular risk in younger women, but increased risk was evident in women aged 70 years and older.
This article was originally published on MedicalXpress.com